Literature DB >> 23062908

Infliximab therapy failure in two patients with pemphigus vulgaris.

Ana García-Rabasco, Mercè Alsina-Gibert, Ignasi Pau-Charles, Pilar Iranzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23062908     DOI： 10.1016/j.jaad.2011.05.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  [Off-label use of infliximab].

Authors:  M Onder; C Salavastru; K Fritz
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

Review 2.  Immunotherapy for Pemphigus: Present and Future.

Authors:  Huijie Yuan; Meng Pan; Hongxiang Chen; Xuming Mao
Journal:  Front Med (Lausanne)       Date:  2022-06-15

3.  Prediction of survival for patients with pemphigus vulgaris and pemphigus foliaceus: a retrospective cohort study.

Authors:  Adrian Baican; Roxana Chiorean; Daniel Corneliu Leucuta; Corina Baican; Sorina Danescu; Dorina Ciuce; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2015-04-22       Impact factor: 4.123

Review 4.  Management of pemphigus vulgaris: challenges and solutions.

Authors:  Stamatis Gregoriou; Ourania Efthymiou; Christina Stefanaki; Dimitris Rigopoulos
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-21

Review 5.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.